+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "HTLV Testing"

Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) - Product Thumbnail Image

Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

  • Report
  • June 2021
  • Global
From
Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model - Product Thumbnail Image

Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model

  • Report
  • December 2018
  • Global
From
2022-2026 Global HTLV-I/II Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global HTLV-I/II Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Human T-cell Leukemia Virus (HTLV) testing market is a subset of the larger infectious disease testing market. HTLV testing is used to detect the presence of the virus in individuals, which can cause a variety of diseases, including adult T-cell leukemia/lymphoma and HTLV-associated myelopathy/tropical spastic paraparesis. HTLV testing is typically done through a blood test, and is used to diagnose and monitor the progression of the virus. HTLV testing is used in a variety of settings, including clinical laboratories, hospitals, and research institutions. It is also used to screen blood donors for the virus, as well as to diagnose and monitor individuals who are at risk of infection. Companies in the HTLV testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, and Siemens Healthineers. Show Less Read more